Teva Pharmaceutical Industries (TEVA) Short Interest Ratio & Short Volume $17.07 +0.43 (+2.58%) Closing price 03:59 PM EasternExtended Trading$17.05 -0.02 (-0.12%) As of 07:18 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Short Interest Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock Teva Pharmaceutical Industries Short Interest DataTeva Pharmaceutical Industries (TEVA) has a short interest of 40.00 million shares, representing 3.50% of the float (the number of shares available for trading by the public). This marks a 12.14% increase in short interest from the previous month. The short interest ratio (days to cover) is 3.3, indicating that it would take 3.3 days of the average trading volume of 10.25 million shares to cover all short positions.Current Short Interest40,000,000 sharesPrevious Short Interest35,670,000 sharesChange Vs. Previous Month+12.14%Dollar Volume Sold Short$679.88 millionShort Interest Ratio3.3 Days to CoverLast Record DateJune 15, 2025Outstanding Shares1,146,960,000 sharesShort Percent of Float3.50%Today's Trading Volume10,813,139 sharesAverage Trading Volume10,250,053 sharesToday's Volume Vs. Average105% Short Selling Teva Pharmaceutical Industries? Sign up to receive the latest short interest report for Teva Pharmaceutical Industries and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort Interest ChartDays to Cover ChartShort Percent of Float ChartTEVA Short Interest Over TimeTEVA Days to Cover Over TimeTEVA Percentage of Float Shorted Over Time Teva Pharmaceutical Industries Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 6/15/202540,000,000 shares $679.88 million +12.1%3.5%3.3 $17.00 5/31/202535,670,000 shares $598.19 million -7.8%3.2%2.9 $16.77 5/15/202538,700,000 shares $651.32 million +36.1%3.4%3.1 $16.83 4/30/202528,430,000 shares $440.95 million -6.3%N/A2.3 $15.51 4/15/202530,340,000 shares $412.17 million -6.3%2.7%2.4 $13.59 3/31/202532,390,000 shares $498.32 million -6.9%2.9%2.5 $15.39 3/15/202534,800,000 shares $569.85 million +25.1%3.1%2.8 $16.38 2/28/202527,810,000 shares $457.47 million +4.3%2.5%2.2 $16.45 2/15/202526,660,000 shares $432.83 million +19.2%2.4%2.2 $16.24 1/31/202522,360,000 shares $398.12 million +41.5%N/A2 $17.81 Get the Latest News and Ratings for TEVA and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Teva Pharmaceutical Industries and its competitors with MarketBeat's FREE daily newsletter. 1/15/202515,800,000 shares $346.02 million -41.8%N/A1.7 $21.90 12/31/202427,130,000 shares $597.95 million +16.8%N/A3.2 $22.04 12/15/202423,220,000 shares $383.13 million +3.6%N/A2.9 $16.50 11/30/202422,410,000 shares $376.04 million +5.8%N/A3.3 $16.78 11/15/202421,190,000 shares $348.26 million +17.1%N/A3.1 $16.44 10/31/202418,090,000 shares $333.76 million -9.1%N/A2.7 $18.45 10/15/202419,910,000 shares $361.57 million -18.7%N/A2.7 $18.16 9/30/202424,490,000 shares $441.31 million -19.3%N/A3 $18.02 9/15/202430,340,000 shares $558.56 million +26.7%N/A3.5 $18.41 8/31/202423,950,000 shares $451.94 million -0.2%N/A2.7 $18.87 8/15/202423,990,000 shares $439.62 million +23.0%N/A2.7 $18.33 7/31/202419,500,000 shares $339.69 million +10.3%N/A1.9 $17.42 7/15/202417,680,000 shares $301.97 million -20.8%N/A1.8 $17.08 6/30/202422,310,000 shares $362.54 million -9.2%N/A2.2 $16.25 6/15/202424,560,000 shares $421.45 million +35.8%N/A2.5 $17.16 5/31/202418,080,000 shares $306.09 million +39.1%N/A1.9 $16.93 5/15/202413,000,000 shares $218.14 million +6.4%N/A1.3 $16.78 4/30/202412,220,000 shares $171.45 million +4.8%N/A1.3 $14.03 4/15/202411,660,000 shares $154.26 million +0.9%N/A1.1 $13.23 3/31/202411,560,000 shares $163.11 million +10.5%N/A1.1 $14.11 3/15/202410,460,000 shares $140.53 million -28.9%N/A1 $13.44 2/29/202414,720,000 shares $193.27 million -4.4%N/A1.4 $13.13 2/15/202415,390,000 shares $202.99 million -16.0%N/A1.5 $13.19 1/31/202418,320,000 shares $221.67 million +9.3%N/A1.8 $12.10 1/15/202416,760,000 shares $189.72 million +2.5%N/A1.9 $11.32 12/31/202316,350,000 shares $170.69 million +15.8%N/A1.9 $10.44 12/15/202314,120,000 shares $140.92 million +6.1%N/A1.7 $9.98 11/30/202313,310,000 shares $130.77 million -6.1%N/A1.5 $9.83 11/15/202314,180,000 shares $127.19 million -18.9%N/A1.7 $8.97 10/31/202317,490,000 shares $150.06 million +19.2%N/A2.1 $8.58Forget Nvidia, This “Ghost Town” Company Holds the Key to the AI Boom (Ad)Cold War Discovery Could Unlock $100 Trillion in Wealth Jeff recently traveled to an American ghost town to investigate this crazy Cold War story… Because it could hold the key to the entire $100 trillion AI boom. It involves an American ghost town with just 30 people… And a new twist to the AI boom that could make a lot of people rich. Click here to see the details on what could be the biggest tech story of this decade. 10/15/202314,670,000 shares $127.04 million +8.1%N/A1.6 $8.66 9/30/202313,570,000 shares $138.41 million -19.5%N/A1.4 $10.20 9/15/202316,850,000 shares $178.10 million -0.3%N/A1.8 $10.57 8/31/202316,900,000 shares $164.94 million -18.4%N/A1.7 $9.76 8/15/202320,710,000 shares $197.47 million -8.8%N/A1.7 $9.54 7/31/202322,710,000 shares $190.65 million +18.7%N/A1.6 $8.40 7/15/202319,130,000 shares $157.06 million +18.7%N/A1.5 $8.21 6/30/202316,120,000 shares $121.30 million -24.4%N/A1.2 $7.53 6/15/202321,330,000 shares $161.68 million +0.1%N/A1.6 $7.58 5/31/202321,300,000 shares $153.15 million +52.5%N/A1.6 $7.19 5/15/202313,970,000 shares $112.74 million +9.7%N/A1.2 $8.07 4/30/202312,730,000 shares $111.13 million -16.6%N/A1.4 $8.73 4/15/202315,260,000 shares $126.51 million -7.4%N/A1.7 $8.29 3/31/202316,480,000 shares $145.85 million -15.9%N/A1.8 $8.85 3/15/202319,590,000 shares $169.85 million -23.4%N/A2.2 $8.67 2/28/202325,570,000 shares $253.40 million -7.6%N/A2.9 $9.91 2/15/202327,680,000 shares $285.38 million -2.4%N/A3.1 $10.31 1/31/202328,350,000 shares $298.81 million +13.3%N/A2.9 $10.54 1/15/202325,020,000 shares $281.22 million -20.5%N/A2.6 $11.24 12/30/202231,470,000 shares $287.01 million +31.2%N/A3.3 $9.12 12/15/202223,980,000 shares $214.86 million -22.7%N/A2.6 $8.96 11/30/202231,030,000 shares $272.13 million +0.7%N/A3.4 $8.77 11/15/202230,810,000 shares $282.84 million +2.1%N/A3.3 $9.18 10/31/202230,190,000 shares $269.29 million +3.8%N/A2.9 $8.92 10/15/202229,080,000 shares $231.19 million -0.2%N/A2.3 $7.95 9/30/202229,150,000 shares $235.24 million +12.4%N/A2.2 $8.07 9/15/202225,940,000 shares $230.61 million +28.0%N/A1.9 $8.89 8/31/202220,270,000 shares $183.24 million -9.8%N/A1.4 $9.04 8/15/202222,460,000 shares $251.55 million +11.8%N/A1.6 $11.20 7/31/202220,090,000 shares $188.44 million +13.1%N/A1.5 $9.38 7/15/202217,760,000 shares $124.50 million +4.1%N/A1.7 $7.01 6/30/202217,060,000 shares $128.29 million -12.0%N/A1.7 $7.52 6/15/202219,380,000 shares $157.56 million +1.8%1.8%1.9 $8.13 5/31/202219,040,000 shares $173.26 million -7.0%N/A2.2 $9.10 5/15/202220,470,000 shares $158.85 million +21.2%N/A2.3 $7.76 4/30/202216,890,000 shares $147.11 million -7.5%N/A1.9 $8.71 4/15/202218,260,000 shares $186.07 million -12.7%N/A2.1 $10.19 3/31/202220,910,000 shares $196.34 million -3.7%N/A2.3 $9.39 3/15/202221,720,000 shares $162.90 million +5.4%N/A2.4 $7.50 2/28/202220,610,000 shares $167.56 million +12.3%N/A2.2 $8.13 2/15/202218,360,000 shares $155.33 million -16.6%N/A1.9 $8.46 1/31/202222,020,000 shares $185.63 million +4.3%N/A2.3 $8.43 1/15/202221,110,000 shares $193.58 million +14.1%N/A2 $9.17 12/31/202118,500,000 shares $148.19 million -7.7%N/A1.9 $8.01 12/15/202120,040,000 shares $163.73 million +3.7%N/A2.1 $8.17 11/30/202119,330,000 shares $159.47 million -1.3%N/A2 $8.25 11/15/202119,590,000 shares $184.93 million +1.8%N/A2.3 $9.44 10/29/202119,240,000 shares $168.16 million +9.4%N/A2.3 $8.74 10/15/202117,590,000 shares $170.27 million -10.3%N/A2.2 $9.68 9/30/202119,600,000 shares $190.90 million -11.8%N/A2.3 $9.74Forget Nvidia, This “Ghost Town” Company Holds the Key to the AI Boom (Ad)Cold War Discovery Could Unlock $100 Trillion in Wealth Jeff recently traveled to an American ghost town to investigate this crazy Cold War story… Because it could hold the key to the entire $100 trillion AI boom. It involves an American ghost town with just 30 people… And a new twist to the AI boom that could make a lot of people rich. Click here to see the details on what could be the biggest tech story of this decade. 9/15/202122,230,000 shares $199.40 million -4.6%N/A2.6 $8.97 8/31/202123,290,000 shares $219.39 million -18.4%N/A2.7 $9.42 8/13/202128,530,000 shares $280.45 million -14.2%N/A3.2 $9.83 7/30/202133,240,000 shares $320.77 million -2.0%N/A3.7 $9.65 7/15/202133,910,000 shares $297.39 million -1.1%N/A3.9 $8.77 6/30/202134,290,000 shares $339.47 million -3.6%N/A4.2 $9.90 6/15/202135,570,000 shares $385.93 million +1.2%N/A4.8 $10.85 5/28/202135,160,000 shares $365.66 million -1.0%N/A4.4 $10.40 5/14/202135,500,000 shares $369.91 million -3.5%3.2%4.3 $10.42 4/30/202136,770,000 shares $391.23 million +23.3%3.3%3.9 $10.64 4/15/202129,830,000 shares $324.55 million +19.1%2.7%3.3 $10.88 3/31/202125,040,000 shares $283.70 million -31.2%2.3%2.7 $11.33 3/15/202136,370,000 shares $392.43 million +13.2%3.3%3.6 $10.79 2/26/202132,140,000 shares $353.54 million -6.8%2.9%3.3 $11.00 2/12/202134,470,000 shares $389.51 million +12.6%3.1%3.7 $11.30 1/29/202130,620,000 shares $375.10 million +2.9%2.8%3.4 $12.25 1/15/202129,750,000 shares $342.13 million No Change2.7%3.3 $11.50 TEVA Short Interest - Frequently Asked Questions What is Teva Pharmaceutical Industries' current short interest? Short interest is the volume of Teva Pharmaceutical Industries shares that have been sold short but have not yet been closed out or covered. As of June 15th, traders have sold 40,000,000 shares of TEVA short. 3.50% of Teva Pharmaceutical Industries' shares are currently sold short. Learn More on Teva Pharmaceutical Industries' current short interest. What is a good short interest ratio for Teva Pharmaceutical Industries? The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. TEVA shares currently have a short interest ratio of 3.0. Learn More on Teva Pharmaceutical Industries's short interest ratio. Which institutional investors are shorting Teva Pharmaceutical Industries? As of the most recent reporting period, the following institutional investors, funds, and major shareholders have reported short positions of Teva Pharmaceutical Industries: Jane Street Group LLC, Goldman Sachs Group Inc., Parallax Volatility Advisers L.P., Millennium Management LLC, CMT Capital Markets Trading GmbH, Capital Markets Trading UK LLP, Cubist Systematic Strategies LLC, Caption Management LLC, Nomura Holdings Inc., Jane Street Group LLC, Walleye Trading LLC, Walleye Capital LLC, Capital Fund Management S.A., Garda Capital Partners LP, Hsbc Holdings PLC, Simplex Trading LLC, Wolverine Asset Management LLC, Citigroup Inc., and IMC Chicago LLC. These positions are disclosed in Form 13F filings with the Securities and Exchange Commission. What is a good short interest percentage for Teva Pharmaceutical Industries? Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 3.50% of Teva Pharmaceutical Industries' floating shares are currently sold short. Is Teva Pharmaceutical Industries' short interest increasing or decreasing? Teva Pharmaceutical Industries saw a increase in short interest during the month of June. As of June 15th, there was short interest totaling 40,000,000 shares, an increase of 12.1% from the previous total of 35,670,000 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. How does Teva Pharmaceutical Industries' short interest compare to its competitors? 3.50% of Teva Pharmaceutical Industries' shares are currently sold short. Here is how the short interest of companies in the industry of "pharmaceutical products" compare to Teva Pharmaceutical Industries: Takeda Pharmaceutical Co. (0.21%), argenex SE (3.39%), BioNTech SE Sponsored ADR (2.58%), Summit Therapeutics PLC (27.22%), Intra-Cellular Therapies, Inc. (2.58%), Genmab A/S Sponsored ADR (0.36%), Dr. Reddy's Laboratories Ltd (1.52%), Ascendis Pharma A/S (7.33%), Viatris Inc. (3.74%), Qiagen N.V. (2.63%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: SPDR S&P 500 ETF Trust ($69.26 billion), Invesco QQQ ($25.22 billion), iShares Russell 2000 ETF ($20.33 billion), iShares 20+ Year Treasury Bond ETF ($9.99 billion), MicroStrategy Incorporated ($9.12 billion), Canadian Natural Resources Limited ($6.73 billion), SPDR S&P Biotech ETF ($6.52 billion), Invesco S&P 500 Equal Weight ETF ($5.60 billion), Financial Select Sector SPDR Fund ($4.64 billion), and iShares iBoxx $ Investment Grade Corporate Bond ETF ($4.59 billion). View all of the most shorted stocks. What does it mean to sell short Teva Pharmaceutical Industries stock? Short selling TEVA is an investing strategy that aims to generate trading profit from Teva Pharmaceutical Industries as its price is falling. TEVA shares are trading up $0.43 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Teva Pharmaceutical Industries? A short squeeze for Teva Pharmaceutical Industries occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of TEVA, which in turn drives the price of the stock up even further. How often is Teva Pharmaceutical Industries' short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including TEVA, twice per month. The most recent reporting period available is June, 15 2025. More Short Interest Resources from MarketBeat Related Companies TAK Short Squeeze ARGX Short Squeeze BNTX Short Squeeze SMMT Short Squeeze ITCI Short Squeeze GMAB Short Squeeze RDY Short Squeeze ASND Short Squeeze VTRS Short Squeeze QGEN Short Squeeze Short Interest Tools Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NYSE:TEVA) was last updated on 7/2/2025 by MarketBeat.com Staff From Our PartnersGet Your Bank Account “Fed Invasion” Ready with THESE 4 Simple StepsStarting as soon as a few months from now, the United States government will make a sweeping change to bank ac...Weiss Ratings | SponsoredBuffett’s $325 Billion Cash Problem — Solved by Gold?A bombshell announcement is just weeks away — and it could send shockwaves through the gold market. Most inves...Golden Portfolio | SponsoredAI Meltdown Imminent: Dump These Stocks Now!If you have any money in the markets, especially in AI stocks… Please click here to see Elon Musk’s new inv...Paradigm Press | SponsoredIsrael-Iran WAR Could Destroy Trump's PresidencyThe missiles are already flying. Israel and Iran are now in direct military conflict — and this couldn't ha...American Alternative | SponsoredSomething very strange is happening...What a "Mar-a-Lago Accord" could mean for the U.S. dollar While protests dominate the news... hardly anyone...Stansberry Research | SponsoredElon’s BIGGEST warning yet?Tesla's About to Prove Everyone Wrong... Again Back in 2018, when Jeff Brown told everyone to buy Tesla… ...Brownstone Research | SponsoredCrypto Is Pumping Again – Now Comes the Real OpportunityThis same signal has appeared twice before in the past 8 years — both times, it kicked off major moves in cryp...Crypto Swap Profits | SponsoredTrump’s treachery Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Teva Pharmaceutical Industries Ltd. Please log in to your account or sign up in order to add this asset to your watchlist. Share Teva Pharmaceutical Industries With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free TEVA Stock Alerts